Page last updated: 2024-08-23

epirubicin and Budd-Chiari Syndrome

epirubicin has been researched along with Budd-Chiari Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duan, F; Fan, QS; Liu, FY; Song, P; Wang, MQ; Wang, Y	1

Other Studies

1 other study(ies) available for epirubicin and Budd-Chiari Syndrome

Article	Year
Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization. BMC gastroenterology, 2013, Jun-24, Volume: 13 Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stents; Tomography, X-Ray Computed	2013

Article

Year

Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.

BMC gastroenterology, 2013, Jun-24, Volume: 13

Topics: Adult; alpha-Fetoproteins; Angiography; Angioplasty; Antineoplastic Combined Chemotherapy Protocols; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stents; Tomography, X-Ray Computed

2013